As the methylation levels of CR1, CLU, and PICALM are not related to MMSE scores, methylation levels in the CpG island shores of these genes in the blood of AD patients may have already been lower than those in controls before the onset of the disease. The gene discussed is CLU; the disease is Alzheimer disease.